Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation

2018 ◽  
Vol 15 (11) ◽  
pp. e1800289 ◽  
Author(s):  
Hong-Wei Han ◽  
Hong-Yan Lin ◽  
De-Liu He ◽  
Yao Ren ◽  
Wen-Xue Sun ◽  
...  
Author(s):  
Serdar Burmaoglu ◽  
Derya Aktas Anil ◽  
Arzu Gobek ◽  
Deryanur Kilic ◽  
Derya Yetkin ◽  
...  

RSC Advances ◽  
2018 ◽  
Vol 8 (60) ◽  
pp. 34266-34274 ◽  
Author(s):  
Lei Zhang ◽  
Ying Rong ◽  
Jie Zheng ◽  
Chengli Yang ◽  
Yongzheng Chen ◽  
...  

Conjugate S1 exhibited potential antiproliferative activity against multi-drug resistant leukemia cells.


Heterocycles ◽  
2014 ◽  
Vol 89 (8) ◽  
pp. 1923 ◽  
Author(s):  
Zhenmin Mao ◽  
Ping Zhao ◽  
Yun Yan ◽  
Yanzhong Li ◽  
Aiying Zhang ◽  
...  

2020 ◽  
Vol 27 (40) ◽  
pp. 6787-6814 ◽  
Author(s):  
Lin-Ying Xia ◽  
Ya-Liang Zhang ◽  
Rong Yang ◽  
Zhong-Chang Wang ◽  
Ya-Dong Lu ◽  
...  

Due to the three domains of the colchicine-site which is conducive to the combination with small molecule compounds, colchicine-site on the tubulin has become a common target for antitumor drug development, and accordingly, a large number of tubulin inhibitors binding to the colchicine-site have been reported and evaluated over the past years. In this study, tubulin inhibitors targeting the colchicine-site and their application as antitumor agents were reviewed based on the literature from 2015 to 2019. Tubulin inhibitors were classified into ten categories according to the structural features, including colchicine derivatives, CA-4 analogs, chalcone analogs, coumarin analogs, indole hybrids, quinoline and quinazoline analogs, lignan and podophyllotoxin derivatives, phenothiazine analogs, N-heterocycle hybrids and others. Most of them displayed potent antitumor activity, including antiproliferative effects against Multi-Drug-Resistant (MDR) cell lines and antivascular properties, both in vitro and in vivo. In this review, the design, synthesis and the analysis of the structure-activity relationship of tubulin inhibitors targeting the colchicine-site were described in detail. In addition, multi-target inhibitors, anti-MDR compounds, and inhibitors bearing antitumor activity in vivo are further listed in tables to present a clear picture of potent tubulin inhibitors, which could be beneficial for medicinal chemistry researchers.


2015 ◽  
Vol 25 (8) ◽  
pp. 1730-1735 ◽  
Author(s):  
Xiao-Meng Wang ◽  
Jing Xu ◽  
Min-Hang Xin ◽  
She-Min Lu ◽  
San-Qi Zhang

2020 ◽  
Vol 30 (12) ◽  
pp. 127194 ◽  
Author(s):  
Hao-Yue Xiang ◽  
Yan-Hong Chen ◽  
Yi Wang ◽  
Xi Zhang ◽  
Jian Ding ◽  
...  

Heterocycles ◽  
2016 ◽  
Vol 92 (12) ◽  
pp. 2145
Author(s):  
Jie Tang ◽  
Jiefeng Zhang ◽  
Fengjie Guan ◽  
Jiakun Qiu ◽  
Yanfen Fang ◽  
...  

ChemMedChem ◽  
2021 ◽  
Author(s):  
Walter Damián Guerra ◽  
Daniel Lucena-Agell ◽  
Rafael Hortigüela ◽  
Roberto Arturo Rossi ◽  
J. Fernando Díaz ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (35) ◽  
pp. 27775-27784 ◽  
Author(s):  
Hong-Yan Lin ◽  
Li-Fei Bai ◽  
Fang Wang ◽  
Xun Wu ◽  
Lu-Jing Han ◽  
...  

S12, the best anticancer agent among the 17 podophyllotoxin derivatives, showed a proliferative inhibition effect via inhibiting tubulin polymerization.


Sign in / Sign up

Export Citation Format

Share Document